StockData
Invivyd, Inc. logo

Invivyd, Inc. (IVVD) stock

IVVDNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 9/3045% below fair value
$0.51−0.03 (-4.67%)

Close on Nov 17, 2026Market cap $151.09MP/E –Yield –

Invivyd EPS

Diluted earnings per share is net income divided by the share count including options and convertible securities.

Invivyd's EPS for the twelve months ending Jun 30, 2026 was -$0.37. For fiscal 2025 it was -$0.30. The highest annual figure on record is -$0.30 in fiscal 2025.

Annual eps

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$0.30–
FY2024Dec 31, 2024-$1.43–
FY2023Dec 31, 2023-$1.81–
FY2022Dec 31, 2022-$2.23–
FY2021Dec 31, 2021-$5.32–

Quarterly eps

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$0.14–
Q1 FY2026Mar 31, 2026-$0.13–
Q4 FY2025Dec 31, 2025-$0.04–
Q3 FY2025Sep 30, 2025-$0.06–
Q2 FY2025Jun 30, 2025-$0.12–
Q1 FY2025Mar 31, 2025-$0.14–
Q4 FY2024Dec 31, 2024-$0.15–
Q3 FY2024Sep 30, 2024-$0.51–
Q2 FY2024Jun 30, 2024-$0.40–
Q1 FY2024Mar 31, 2024-$0.38–
Q4 FY2023Dec 31, 2023-$0.67–
Q3 FY2023Sep 30, 2023-$0.36–
Q2 FY2023Jun 30, 2023-$0.46–
Q1 FY2023Mar 31, 2023-$0.32–
Q4 FY2022Dec 31, 2022-$0.41–
Q3 FY2022Sep 30, 2022-$0.42–
Q2 FY2022Jun 30, 2022-$0.47–
Q1 FY2022Mar 31, 2022-$0.93–
Q3 FY2021Sep 30, 2021-$0.98–
Q2 FY2021Jun 30, 2021-$178.86–
Q1 FY2021Mar 31, 2021$0.00–
Q3 FY2020Sep 30, 2020-$25.98–

More Invivyd figures

See a number that looks wrong?